Quick Links
HB 5303 — Biomedical Research
by Health Care Appropriations Subcommittee; Rep. Hudson
This summary is provided for information only and does not represent the opinion of any Senator, Senate Officer, or Senate Office.
Prepared by: Budget Committee (BC)
The bill provides statutory changes to conform to the FY 2011-2012 General Appropriations Act. Specifically, the bill revises provisions of s. 216.5602 (12), F.S., as follows:
- Modifies the amount of revenue from the cigarette surcharge deposited in the Health Care Trust Fund to be reserved and subsequently transferred to the Biomedical Research Trust Fund within the Department of Health from $50 million to $25 million beginning in the 2011-2012 fiscal year. Allocation of the funds is subject to an annual appropriation in the General Appropriations Act.
- Decreases the amount of funding provided to the James and Esther King Biomedical Research Program and the William G. “Bill” Bankhead Coley Cancer Research Program from $20 million each to $5 million each.
- Decreases the amount of funding provided to the H. Lee Moffitt Cancer Center and Research Program from $10 to $5 million.
- Provides $5 million each to the Sylvester Cancer Center at the University of Miami and the Shands Cancer Center at the University of Florida for cancer research activities. The 2011-12 General Appropriations Act appropriates $5 million to the Shands Cancer Hospital, not the Shands Cancer Center. This is an error in the bill and Senator Negron made a statement on the Floor of the Senate indicating his intent that the funds go to the Shands Cancer Hospital.
If approved by the Governor, these provisions take effect July 1, 2011.
Vote: Senate 31-7; House 115-0